Member Info for daveycaferacer

LoveSingh1, with a small amount of respect I doubt most people are interested in your targets

mjng - sorry to disappoint you but close today was above the issue price, which is a very Bullish sign, not the bearish sign you wanted.

I have a US SSN :o-)

Looking forward to the next big news which will be StemprintER. I hope the Co. provides more detail about how they will launch and commercialise it. I asked the question at the Investor meeting and the answer was they were launch on their own in Italy first. I am not sure how you do that without a local sales/detailing Team unless they will just focus on the main Milan Cancer hospital initially, where they are already quite familiar with it already.

Your Broker won't let you trade ADR's on NASDAQ unless you have filled in and registered a form W-8BEN, unless you are lucky like me and have UK and U.S residency so have direct access to the U.S. market domestically!

". Are current shareholders as of record date actually are meant to receive new shares because TILS issued additional equity?"
No, but that would be nice, every time a Company issues new shares Investors get given them for nothing! ;o-))

StemprintER will be demerged by way of capital reduction into a newco called Accustem Biosciences - existing TILS holders will be given new stock on the newco on a pro-rate basis

eh! I've been robbed @ 222p!!

Tiziana Life Sciences pioneering novel approach to COVID-19 treatment, says analyst

https://www.proactiveinvestors.co.uk/companies/news/925912/tiziana-life-sciences-pioneering-novel-approach-to-covid-19-treatment-says-analyst-925912.html

NL1234, thanks and I am fully supportive of people posting negative or contrarian views if they state their position. The problem is some Bulletin Boards are infiltrated by people from the share tipping website I mentioned earlier, who use underhand tactics to sew seeds of doubt and are therefore deliberately opaque in their arguments.

great response Bekind! good luck to you....

More material news is on its way ;o-))

"Good find NK1234, we must make an informed decision."

More people on here trying to sew seeds of doubt and like the grubby little share tipping website, probably do not realise how ADR's work or the fact that NASDAQ controls the price now, including the London price.

It was very well known if you had researched the Company & its Directors.

What's your decision then Bekind?

I was aware they were Directors but the people at the share tipping website I referred to have deliberately cherry picked negatives only in order to sew seeds of doubt amongst people who will sell at the drop of a hat, which suits the short agenda. This Company has a lost of cash now and what the grubby little share tipping website fails to acknowledge is all the positives or the fact that on balance Gabriele & Kunwar have sold Companies for a lot of money and are very very successful on the whole, albeit with a few failures along the way.

that is false information I saw yesterday being touted across all the bulletin boards by multiple people/aliases from the rancid little share tipping website. It went chapter 11 and was acquired by Bausch. I don't see how that is relevant here.

Thankyou Jatw & amones
Yes, maybe a bit too positive at times, I admit I am very very enthusiastic about the Company, its Management Team and their fantastic achievements. It has been frustrating to me that the market seems to either under-value or over-value the company based on events outside the Company's control.

In that context I think all they can do is to keep calm, carry on and deliver for patients and execute their Corporate strategy, which will ultimately deliver for Investors too.

I am surprised some of the more recently appointed Directors haven't made share purchases but hope that will change.

With regards to the AIM listing I suspect the Company sees little advantage to move to a main Listing given the fact NASDAQ and the specialist Biopharma Investors in the U.S. are what matter most. I may be wrong doubt the Company sees any specific benefit in moving off AIM.

As for a HK listing, I was disappointed that didn't happen because it seems to me opening up the Company to a huge pool of Asian Investors would be very beneficial. It is rare to see a company with listings in 2 Countries/continents outside of its own primary operating region.

Given the GA investment, with a possible further $100m to come, and the fact we could become cashflow positive in 2023 or 2024 I am not sure the Company will need to conduct another placing/IPO but I may be wrong on that. I assume that will partly depend on the success of Surufatinib in particular and how quickly we can get a launch in the United States.

the fickle, the weak, the inexperienced small time rainbow chasers are largely out, which is a good thing, the bashers have no doubt moved on to their next target, hopefully we can all get back to talking about the Company and the investment case.

I am looking forward to more coverage and some decent Analayst coverage together with an update on Accustem

"Forgive my ignorance...who are these Pizza gang?"

Believe me, you do not want to know

Tiziana Life Sciences upgraded by influential BidaskClub to strong-buy.

https://www.marketbeat.com/stocks/NASDAQ/TLSA/?RegistrationCode=SocialMedia-StockTwits&utm_source=GeneralSocialMedia&utm_medium=Social&utm_campaign=SocialMedia

Unfortunately many investors who see talk of flashy cars, yachts and sunseekers on bulletin boards will see it as a red flag and run a mile ;-))

"Why should I put my money into this share? No blatant ramping just facts!"

The only person I have ever put that question to in over 30 years of investing is the Chief Executive of a Company. By the way, you are not "putting money into this share" you are investing in the Company.

LoveSingh1 you are filtered for being disingenuous and opaque towards others

Thankyou for posting those Jatw, still way undervalued and it's nice to see Mark Slater saying that recently too